Financial News Conference on Fiscal 2024

Bayer meets adjusted guidance and takes decisive action to tackle challenges

• 2025 to be a pivotal year for company’s turnaround – improved performance expected from 2026 onwards
• Comprehensive plan to boost profitability at Crop Science
• Progress on strategic priorities
• 2024 Group sales at 46.606 billion euros (Fx & p adj. plus 0.7 percent), negative currency effects of 1.349 billion euros
• EBITDA before special items at 10.123 billion euros (minus 13.5 percent)
• Core earnings per share at 5.05 euros (minus 21.0 percent)
• Net income at minus 2.552 billion euros, impairment losses at Crop Science
• Free cash flow increases to 3.107 billion euros, net financial debt reduced to 32.626 billion euros
• Proposed dividend of 0.11 euros per share
• Outlook for 2025: Sales roughly at prior-year level, EBITDA before special items and core EPS to decline

NEWS RELEASE

Annual Report